Breaking News Instant updates and real-time market news.

JELD

Jeld-Wen

$21.96

1.55 (7.59%)

09:22
11/26/19
11/26
09:22
11/26/19
09:22

Jeld-Wen upgraded to Outperform at Baird

as reported previously, Baird analyst Timothy Wojs upgraded Jeld-Wen to Outperform from Neutral. The analyst raised his estimates above consensus citing the recent pricing actions with North American interior doors and the company's additional pricing increase. He sees improving pricing sentiment and shares discounted verse peers setting up an attractive risk/reward for the shares. Wojs raised his price target to $26 from $22 on Jeld-Wen shares.

  • 03

    Dec

JELD Jeld-Wen
$21.96

1.55 (7.59%)

03/15/19
GHSC
03/15/19
INITIATION
Target $26
GHSC
Buy
Jeld-Wen initiated with a Buy at Seaport Global
Seaport Global analyst Reuben Garner initiated Jeld-Wen with a Buy rating and a price target of $26, citing "company specific drivers" outside his optimistic outlook on the U.S. housing market. The analyst cites "elimination of operations issues" driving faster revenue growth for Jeld-Wen, as well as the increasing focus on the company's margins under a new management. Garner sees earnings growth of over 15% per year through 2022 from the "savings initiatives alone" and contends that the valuation hit in the replace and remodel door space coming mostly from the Jeld-Wen / Steves & Sons lawsuit is "not commensurate with fundamental improvements" at the company.
10/14/19
RILY
10/14/19
NO CHANGE
Target $18
RILY
Neutral
Jeld-Wen price target lowered to $18 from $21 at B. Riley FBR
B. Riley FBR analyst Alex Rygiel lowered his price target for Jeld-Wen to $18 from $21 after the company last week preannounced weaker than expected preliminary Q3 results. The analyst, who reduced his estimates for 2019 and 2020, believes Jeld-Wen is positioned to benefit from more recent positive U.S. housing starts and permits data and strong homebuilder order growth in 2020. He reiterates a Neutral rating on the name.
10/14/19
RBCM
10/14/19
NO CHANGE
Target $17
RBCM
Sector Perform
Jeld-Wen price target lowered to $17 from $20 at RBC Capital
RBC Capital analyst Mike Dahl lowered his price target on Jeld-Wen to $17 and kept his Sector Perform rating after its worse than expected Q3 pre-announcement when the company reported preliminary Q3 revenue of $1.09B vs. $1.1B consensus and adjusted EBITDA of $106M-$110M - down from $132.6M last year - last Thursday. The analyst is lowering his FY19 and FY20 adjusted EBITDA view by $38M and $44M to $428M and $450M respectively, noting that his volume outlook for North America and Australasia are showing deterioration. Dahl adds that while Jeld-Wen management expects internal headwinds to ease in Q4, operational inefficiencies tend to linger longer than expected.
11/26/19
BARD
11/26/19
UPGRADE
Target $26
BARD
Outperform
Jeld-Wen upgraded to Outperform from Neutral at Baird
Baird analyst Timothy Wojs upgraded Jeld-Wen to Outperform from Neutral with a $26 price target.

TODAY'S FREE FLY STORIES

IWM

iShares Trust Russell 2000 Index Fund

$163.03

-0.92 (-0.56%)

, RUT

Russell 2000 Index

$0.00

(0.00%)

15:19
12/13/19
12/13
15:19
12/13/19
15:19
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

For the week, the Russell…

IWM

iShares Trust Russell 2000 Index Fund

$163.03

-0.92 (-0.56%)

RUT

Russell 2000 Index

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$60.31

-0.55 (-0.90%)

, XLB

S&P Select Materials SPDR

$60.50

-0.42 (-0.69%)

15:18
12/13/19
12/13
15:18
12/13/19
15:18
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

The S&P 500 (SPX)…

XLE

Energy Select Sector SPDR

$60.31

-0.55 (-0.90%)

XLB

S&P Select Materials SPDR

$60.50

-0.42 (-0.69%)

XLK

Technology Select Sector SPDR

$89.50

0.61 (0.69%)

XLI

Industrial Select Sector SPDR

$81.67

-0.25 (-0.31%)

XLF

Financial Select Sector

$30.71

-0.11 (-0.36%)

XLU

Utilities SPDR

$63.39

0.53 (0.84%)

SPY

SPDR S&P 500 ETF Trust

$317.32

0.18 (0.06%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
12/13/19
12/13
15:17
12/13/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
12/13/19
12/13
15:16
12/13/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DELL

Dell Technologies

$49.35

-0.15 (-0.30%)

, NTNX

Nutanix

$32.95

0.34 (1.04%)

15:15
12/13/19
12/13
15:15
12/13/19
15:15
Periodicals
Dell looking to broaden infrastructure lead on Nutanix, CRN says »

Dell Technologies (DELL)…

DELL

Dell Technologies

$49.35

-0.15 (-0.30%)

NTNX

Nutanix

$32.95

0.34 (1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 16

    Dec

  • 09

    Jan

  • 27

    Feb

GOOS

Canada Goose

$40.14

-0.005 (-0.01%)

15:14
12/13/19
12/13
15:14
12/13/19
15:14
Periodicals
DA Davidson analyst sees Canada Goose prices falling, NY Post says »

DA Davidson analyst John…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$357.87

-1.83 (-0.51%)

15:04
12/13/19
12/13
15:04
12/13/19
15:04
Periodicals
NHTSA to probe December 7 crash of Tesla Model 3, Reuters reports »

The agency will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 23

    Mar

LYV

Live Nation

$70.64

1.2 (1.73%)

15:02
12/13/19
12/13
15:02
12/13/19
15:02
Periodicals
DoJ preparing to take legal action against Live Nation over ticketing, WSJ says »

The Department of Justice…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:00
12/13/19
12/13
15:00
12/13/19
15:00
General news
Treasury Market Summary »

Treasury Market Summary:…

LYV

Live Nation

$70.63

1.19 (1.71%)

14:57
12/13/19
12/13
14:57
12/13/19
14:57
Periodicals
DOJ preparing to take legal action against Live Nation over ticketing, WSJ says »

The Department of Justice…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGRX

Eagle Pharmaceuticals

$59.90

0.73 (1.23%)

, LLY

Eli Lilly

$121.30

-0.39 (-0.32%)

14:55
12/13/19
12/13
14:55
12/13/19
14:55
Hot Stocks
Eagle Pharmaceuticals reports settlement agreement with Eli Lilly on Pemfexy »

Eagle Pharmaceuticals…

EGRX

Eagle Pharmaceuticals

$59.90

0.73 (1.23%)

LLY

Eli Lilly

$121.30

-0.39 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

  • 17

    Dec

  • 30

    Jan

BMY

Bristol-Myers

$64.01

0.05 (0.08%)

, GILD

Gilead

$65.67

-1.97 (-2.91%)

14:52
12/13/19
12/13
14:52
12/13/19
14:52
Periodicals
Bristol-Myers awarded $585M in damages in patent win over Gilead, Bloomberg says »

Bristol-Myers Squibb…

BMY

Bristol-Myers

$64.01

0.05 (0.08%)

GILD

Gilead

$65.67

-1.97 (-2.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

BRFRF

Burford Capital

$0.00

(0.00%)

14:46
12/13/19
12/13
14:46
12/13/19
14:46
Hot Stocks
Muddy Waters' Block says still short Burford Capital »

Muddy Waters' Carson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANDE

Andersons

$24.03

-0.35 (-1.44%)

14:37
12/13/19
12/13
14:37
12/13/19
14:37
Hot Stocks
Andersons raises dividend to 17.5c from 17c per share »

The Andersons announces a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNDM

TNDM

, MDT

Medtronic

$113.56

1.17 (1.04%)

14:36
12/13/19
12/13
14:36
12/13/19
14:36
Recommendations
TNDM, Medtronic analyst commentary  »

Craig-Hallum reiterates…

TNDM

TNDM

MDT

Medtronic

$113.56

1.17 (1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

BMY

Bristol-Myers

$64.19

0.23 (0.36%)

, GILD

Gilead

$65.76

-1.88 (-2.78%)

14:30
12/13/19
12/13
14:30
12/13/19
14:30
Periodicals
Bristol-Myers awarded $585M in damages in patent win over Gilead, Bloomberg says »

Bristol-Myers (BMY) was…

BMY

Bristol-Myers

$64.19

0.23 (0.36%)

GILD

Gilead

$65.76

-1.88 (-2.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
12/13/19
12/13
14:17
12/13/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
12/13/19
12/13
14:16
12/13/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOO

Vanguard S&P 500 ETF

$291.59

0.33 (0.11%)

, IVV

iShares Core S&P 500

$319.25

0.36 (0.11%)

14:08
12/13/19
12/13
14:08
12/13/19
14:08
Technical Analysis
On The Fly: ETF fund flow highlights »

For the second week,…

VOO

Vanguard S&P 500 ETF

$291.59

0.33 (0.11%)

IVV

iShares Core S&P 500

$319.25

0.36 (0.11%)

XLE

Energy Select Sector SPDR

$60.65

-0.21 (-0.35%)

XLF

Financial Select Sector

$30.74

-0.08 (-0.26%)

QQQ

Invesco QQQ Trust

$207.32

0.76 (0.37%)

SPY

SPDR S&P 500 ETF Trust

$317.43

0.29 (0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNDM

TNDM

14:01
12/13/19
12/13
14:01
12/13/19
14:01
Hot Stocks
Tandem Diabetes up 5% upon resumption following FDA approval news »

After resuming trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNDM

TNDM

14:00
12/13/19
12/13
14:00
12/13/19
14:00
Hot Stocks
Breaking Hot Stocks news story on TNDM »

Tandem Diabetes trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRTX

Vertex

$218.24

-2.19 (-0.99%)

13:57
12/13/19
12/13
13:57
12/13/19
13:57
Hot Stocks
Vertex expands long-term CF medicines reimbursement agreement with Ireland »

Vertex Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

13:55
12/13/19
12/13
13:55
12/13/19
13:55
General news
Action Economics Survey results: »

Action Economics Survey…

SNE

Sony

$67.65

0.34 (0.51%)

, T

AT&T

$38.15

-0.2 (-0.52%)

13:52
12/13/19
12/13
13:52
12/13/19
13:52
On The Fly
Box Office Battle: 'Jumanji' sequel expected to dethrone 'Frozen II' »

Welcome to "Box Office…

SNE

Sony

$67.65

0.34 (0.51%)

T

AT&T

$38.15

-0.2 (-0.52%)

CMCSA

Comcast

$43.59

0.57 (1.33%)

CMCSK

Comcast

$0.00

(0.00%)

LGF.A

Lionsgate

$9.81

-0.18 (-1.80%)

LGF.B

Lionsgate

$9.15

-0.2 (-2.14%)

DIS

Disney

$147.58

1.61 (1.10%)

FOX

Fox Corp.

$36.01

0.05 (0.14%)

FOXA

Fox Corp.

$36.90

0.04 (0.11%)

VIAC

ViacomCBS

$38.51

0.72 (1.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 29

    Jan

T

AT&T

$38.20

-0.15 (-0.39%)

13:45
12/13/19
12/13
13:45
12/13/19
13:45
Hot Stocks
AT&T 'well ahead' of 2019 deleveraging goals »

AT&T has supported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.